Literature DB >> 23250725

SLUG silencing increases radiosensitivity of melanoma cells in vitro.

Chiara Arienti1, Anna Tesei, Silvia Carloni, Paola Ulivi, Antonino Romeo, Giulia Ghigi, Enrico Menghi, Anna Sarnelli, Elisabetta Parisi, Rosella Silvestrini, Wainer Zoli.   

Abstract

BACKGROUND: Melanoma radioresistance has been attributed to the presence of tumor cells with highly efficient DNA damage repair mechanisms. We examined the expression of genes involved in DNA damage repair and DNA damage sensing, and assessed their modulation by SLUG silencing, which is potentially capable of increasing radiosensitivity.
METHODS: Two melanoma cell lines (M14 and M79) were used to evaluate in vitro radiation-induced cytotoxicity before and after SLUG silencing. mRNA expression levels of BRCA1, ERCC1, DNA-PK, PARP, MGMT, ATM and TGM2 were determined by real-time RT-PCR, and protein expression levels of SLUG, caspase 3, p21, PUMA and pMAPK by Western blotting.
RESULTS: The cytotoxic effect of radiation was high in M14 and low in M79 cells. SLUG silencing increased the interference of radiation on cell cycle distribution and cell killing by 60 % and 80 % in M79 cells after a 2.4 Gy and 5 Gy radiation dose, respectively. It also led to a significant inhibition of expression of genes involved in DNA damage repair and DNA damage sensing in all cell lines maintained after radiation. An almost total inhibition was observed for TGM2, which is expressed at a high basal level in the most radioresistant cell line (M79). Protein expression of PUMA was induced by radiation and was enhanced after SLUG silencing.
CONCLUSIONS: Our results reveal a pivotal role of SLUG in regulating a cellular network involved in the response to DNA damage, and highlight the importance of TGM2 in radiosensitivity modulation. SLUG silencing appears to increase radiation sensitivity of the melanoma cells tested.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250725     DOI: 10.1007/s13402-012-0120-6

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  35 in total

1.  Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas.

Authors:  Kejun Zhang; Bingyuan Zhang; Yun Lu; Chuandong Sun; Wei Zhao; Xuelong Jiao; Jilin Hu; Peng Mu; Hai Lu; Changyong Zhou
Journal:  Med Oncol       Date:  2010-12-01       Impact factor: 3.064

2.  Slug, a zinc finger gene previously implicated in the early patterning of the mesoderm and the neural crest, is also involved in chick limb development.

Authors:  M A Ros; M Sefton; M A Nieto
Journal:  Development       Date:  1997-05       Impact factor: 6.868

3.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

4.  A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.

Authors:  Kenneth R Olivier; Steven E Schild; Christopher G Morris; Paul D Brown; Svetomir N Markovic
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

5.  Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.

Authors:  Ivan Vannini; Massimiliano Bonafe; Anna Tesei; Marco Rosetti; Francesco Fabbri; Gianluca Storci; Paola Ulivi; Giovanni Brigliadori; Dino Amadori; Wainer Zoli
Journal:  Cell Oncol       Date:  2007       Impact factor: 6.730

6.  Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies.

Authors:  Bea Pauwels; Annelies E C Korst; Christel M J de Pooter; Greet G O Pattyn; Hilde A J Lambrechts; Marc F D Baay; Filip Lardon; Jan B Vermorken
Journal:  Cancer Chemother Pharmacol       Date:  2003-01-22       Impact factor: 3.333

7.  TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.

Authors:  Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Toshiki Hitora; Mitsuyoshi Tei; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2009-12-22       Impact factor: 5.344

Review 8.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

9.  RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA.

Authors:  Kejun Zhang; Dong Chen; Xingang Wang; Shaoyan Zhang; Jigang Wang; Yuan Gao; Bomin Yan
Journal:  Int J Mol Sci       Date:  2011-01-14       Impact factor: 5.923

10.  Transcriptomal profiling of the cellular response to DNA damage mediated by Slug (Snai2).

Authors:  M Pérez-Caro; C Bermejo-Rodríguez; I González-Herrero; M Sánchez-Beato; M A Piris; I Sánchez-García
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

View more
  10 in total

1.  Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1.

Authors:  Hongxia Yang; Gang Zhang; Xiaolin Che; Shudong Yu
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

2.  Fatal autoimmunity results from the conditional deletion of Snai2 and Snai3.

Authors:  Peter D Pioli; Xinjian Chen; Janis J Weis; John H Weis
Journal:  Cell Immunol       Date:  2015-02-24       Impact factor: 4.868

3.  Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.

Authors:  Kristina Goetze; Christian G Fabian; Andrea Siebers; Livia Binz; Daniel Faber; Stefano Indraccolo; Giorgia Nardo; Ulrike G A Sattler; Wolfgang Mueller-Klieser
Journal:  Cell Oncol (Dordr)       Date:  2015-08-19       Impact factor: 6.730

4.  CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis.

Authors:  Y M Luo; N X Xia; L Yang; Z Li; H Yang; H J Yu; Y Liu; H Lei; F X Zhou; C H Xie; Y F Zhou
Journal:  Int J Mol Med       Date:  2014-04-02       Impact factor: 4.101

5.  Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.

Authors:  Chiara Arienti; Michele Zanoni; Sara Pignatta; Alberto Del Rio; Silvia Carloni; Michela Tebaldi; Gianluca Tedaldi; Anna Tesei
Journal:  Oncotarget       Date:  2016-04-05

6.  CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer.

Authors:  Jeong-Yub Kim; Hee-Jin Kim; Chan-Woong Jung; Tae Sup Lee; Eun Ho Kim; Myung-Jin Park
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

7.  HOXC10 promotes growth and migration of melanoma by regulating Slug to activate the YAP/TAZ signaling pathway.

Authors:  Yuanxin Miao; Weina Zhang; Su Liu; Xiangfeng Leng; Chunnan Hu; Hao Sun
Journal:  Discov Oncol       Date:  2021-04-26

8.  HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA/Slug axis.

Authors:  Lisha Zheng; Ang Zhang; Jishan Liu; Min Liu; Yikun Zhang
Journal:  Int J Mol Med       Date:  2021-11-05       Impact factor: 4.101

9.  New biomarkers to predict the evolution of in situ breast cancers.

Authors:  S Bravaccini; M M Tumedei; E Scarpi; W Zoli; C Rengucci; L Serra; A Curcio; F Buggi; S Folli; A Rocca; R Maltoni; M Puccetti; D Amadori; R Silvestrini
Journal:  Biomed Res Int       Date:  2014-08-26       Impact factor: 3.411

10.  The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.

Authors:  Ulvi Ahmadov; Daniel Picard; Jasmin Bartl; Manuela Silginer; Marija Trajkovic-Arsic; Nan Qin; Lena Blümel; Marietta Wolter; Jonathan K M Lim; David Pauck; Alina Marie Winkelkotte; Marlen Melcher; Maike Langini; Viktoria Marquardt; Felix Sander; Anja Stefanski; Sascha Steltgens; Christina Hassiepen; Anna Kaufhold; Frauke-Dorothee Meyer; Annette Seibt; Lara Kleinesudeik; Anika Hain; Carsten Münk; Christiane Brigitte Knobbe-Thomsen; Alexander Schramm; Ute Fischer; Gabriel Leprivier; Kai Stühler; Simone Fulda; Jens T Siveke; Felix Distelmaier; Arndt Borkhardt; Michael Weller; Patrick Roth; Guido Reifenberger; Marc Remke
Journal:  Cell Death Dis       Date:  2021-09-28       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.